Blood test and leaflet to guide antibiotic use for respiratory infections
Part of Infections, Lungs & breathing clinical trials.
This trial tests if a quick blood test (C-reactive protein, CRP) and a patient leaflet can help doctors prescribe antibiotics only when needed for adults with respiratory tract infections. It aims to reduce unnecessary antibiotic use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 70 years old
- You have a respiratory infection with symptoms like cough, sore throat, stuffy nose, shortness of breath, or wheezing for less than 2 weeks
- You are not severely ill and don't need urgent hospital care
- You have not taken antibiotics in the last 24 hours
- You are not pregnant
- You can be reached by phone for follow-up and can give your permission
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a simple finger-prick test (C-reactive protein or CRP) can help doctors decide whether antibiotics are needed for adults with a cold or other respiratory infection. If you are an adult with recent symptoms and have not taken antibiotics yet, you may be able to join.
This trial tests a quick, point-of-care test for respiratory infections in primary care. The goal is to help doctors decide when antibiotics are needed, reducing unnecessary use.
This study tests how well a blood test (CRP) and a lung ultrasound (an imaging test using sound waves) can tell what is causing your cough and breathing symptoms. It aims to see if these quick, non-invasive tests can help doctors diagnose lower respiratory infections more accurately.
This trial checks whether using fast test results (PCR from samples, a blood marker called procalcitonin, and sputum appearance) can safely reduce how long you need antibiotics during a severe COPD flare. It may help you receive fewer days of antibiotics while still controlling the infection risk.
This study tests whether measuring two blood markers (MxA and CRP) can help doctors decide if antibiotics or antiviral drugs are needed for a COPD flare-up. It aims to reduce unnecessary antibiotic use while still treating infections effectively.
This trial tests a new approach to treating respiratory infections in adults who are at higher risk of becoming seriously ill but can still be treated in an outpatient clinic. It aims to see if this approach helps prevent severe disease.
Hear when a new CRP trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.